Complex Litigation Blog - Recent Legal News

View updates for:
Published: February 9th, 2017
Zofran lawsuit defendant, GlaxoSmithKline, is trying to convince a federal judge to dismiss fraud claims in hundreds of cases involving the drug’s alleged association with serious birth defects. However, plaintiffs reject assertions that their master pleading  lacks adequate  details regarding ...Read More
Published: February 3rd, 2017
Canadian regulators have issued a new safety warning for Levaquin and other fluoroquinolone antibiotics, after a review identified dozens of serious complications possibly related to their use. The prescribing information for all fluoroquinolones marketed in Canada is now being revised to include in...Read More
Published: January 23rd, 2017
Xarelto lawsuits continue to mount in the federal multidistrict litigation now underway in the U.S. District Court, Eastern District of Louisiana. A newly-released MDL Statistic Report indicates that at least 14,935 cases were pending in the proceeding as of January 17th, an increase of 470 filings ...Read More
Published: January 18th, 2017
The federal court overseeing pretrial proceedings for hundreds of peripheral neuropathy lawsuits filed against the manufacturers of Levaquin and other fluoroquinolone antibiotics convened it most recent Status Conference in December. Minutes posted on the Court’s website indicate that discussions ...Read More
Published: January 9th, 2017
Hundreds of additional Stryker hip lawsuit plaintiffs will benefit from a settlement involving the company’s recalled Rejuvenate and AGB II Modular-Neck stems. According to a statement issued last month by Stryker Corp., the $1 billion settlement program has been extended to individuals who underw...Read More
Published: January 4th, 2017
Federal Mirena IUD lawsuits involving a serious brain injury called Pseudotumor Cerebri could soon be transferred to a single U.S. District Court for coordinated pretrial proceedings. Currently, more than 100 such claims are pending in federal courts around the country, and plaintiffs seeking centra...Read More
Published: December 19th, 2016
The companies behind Xarelto doled out big money to physicians last year as part of their efforts to promote use of the controversial blood thinner. According to ProPublica, these “general payments” came to roughly $28.4 million in 2015, placing Xarelto at the top of its “Dollars for Docs” l...Read More
Published: December 12th, 2016
Another Risperdal gynecomastia plaintiff is presenting his case to a jury in Philadelphia, Pennsylvania. Opening arguments began on December 2nd in the Court of Common Pleas, with the Plaintiff’s attorney telling jurors that the Nebraska man would never have taken Risperdal had the drug’s manufa...Read More
Published: December 7th, 2016
A federal jury has ordered Johnson & Johnson and its DePuy Orthopaedics unit to pay more than $1 billion in compensatory and punitive damages to six plaintiffs who sustained debilitating injuries purportedly associated with a metal-on-metal version of the Pinnacle Hip Replacement System. In doin...Read More
Published: November 29th, 2016
Plaintiffs around the country continue to file Xarelto lawsuits over the serious side effects allegedly associated with the blood-thinning medication. According to an update issued by the U.S. Judicial Panel on Multidistrict Litigation on November 15th, there are now 13,727 cases pending in a centra...Read More
The National Trial Lawyers